Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$84,810
in 1 filing, $85K under 10b5-1 plans

Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Azoy Alexander −$85K Chief Accounting Officer sold 7% of stake

Reading 59 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-21 Azoy Alexander Chief Accounting Officer Exercise or conversion 10b5-1 +2,827 $15.44 $44K 42,408
2026-08-21 Azoy Alexander Chief Accounting Officer Sale 10b5-1 −2,827 $30.00 $85K 39,581
2026-08-21 Azoy Alexander Chief Accounting Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −2,827 3,073
2026-07-10 Jaen Juan C. President Sale 10b5-1 −19,799 $28.61 $566K 822,508
2026-07-10 Jaen Juan C. President Sale 10b5-1 −268 $29.40 $8K 822,240
2026-07-09 Jaen Juan C. President Sale 10b5-1 −48,502 $30.05 $1.5M 842,307
2026-06-24 Jaen Juan C. President Sale 10b5-1 −6,431 $29.66 $191K 890,809
2026-06-23 Jaen Juan C. President Sale 10b5-1 −14,067 $27.69 $389K 898,937
2026-06-23 Jaen Juan C. President Sale 10b5-1 −1,697 $28.06 $48K 897,240
2026-06-22 Jaen Juan C. President Sale 10b5-1 −9,236 $27.03 $250K 913,004
2026-06-11 Tang Carolyn C. General Counsel Exercise or conversion +34,090 $2.57 $88K 184,607
2026-06-11 Tang Carolyn C. General Counsel Exercise or conversion · Stock Option (Right to Buy) −34,090 $2.57 $88K 0
2026-06-11 Ribas Antoni Director Grant or award +5,700 44,300
2026-06-11 Ribas Antoni Director Grant or award · Stock Option (Right to Buy) +16,900 16,900
2026-06-11 Lambert Nicole Director Grant or award +5,700 43,000
2026-06-11 Lambert Nicole Director Grant or award · Stock Option (Right to Buy) +16,900 16,900
2026-06-11 Lacey David L. Director Grant or award +5,700 76,652
2026-06-11 Lacey David L. Director Grant or award · Stock Option (Right to Buy) +16,900 16,900
2026-06-11 Machado Patrick Director Grant or award +5,700 44,300
2026-06-11 Machado Patrick Director Grant or award · Stock Option (Right to Buy) +16,900 16,900

Page 1 of 20 · 381 trades